Vincerx Pharma, Inc. (VINC)
OTCMKTS · Delayed Price · Currency is USD
0.0570
+0.0075 (15.08%)
At close: Jul 22, 2025

Vincerx Pharma Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 20202019
Period Ending
Jul '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019
092522214292
Upgrade
Market Cap Growth
-97.44%-64.95%16.73%-89.91%-26.75%-
Upgrade
Enterprise Value
-407-4196293
Upgrade
Last Close Price
0.065.2623.6020.40203.80418.20
Upgrade
PB Ratio
0.143.252.250.452.1311.52
Upgrade
P/TBV Ratio
0.143.252.250.452.1311.52
Upgrade
Debt / Equity Ratio
--0.220.070.04-
Upgrade
Quick Ratio
1.691.142.475.888.011.63
Upgrade
Current Ratio
1.791.212.636.118.041.67
Upgrade
Return on Equity (ROE)
-3136.43%-431.29%-136.38%-85.12%-62.54%-131.20%
Upgrade
Return on Assets (ROA)
-197.53%-138.54%-68.72%-48.54%-43.30%-
Upgrade
Return on Capital (ROIC)
-850.36%-220.87%-82.16%-55.21%-60.30%-28.19%
Upgrade
Earnings Yield
-7589.98%-340.07%-159.17%-291.41%-18.35%-5.68%
Upgrade
FCF Yield
--295.44%-160.34%-275.77%-15.71%-0.78%
Upgrade
Buyback Yield / Dilution
-135.37%-78.22%-1.29%-22.43%-227.04%-17.65%
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.